Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website

Minerva Neurosciences

Minerva Neurosciences reported $-5349000 in Operating Profit for its fiscal quarter ending in March of 2023.

Operating Profit Change
Acadia Pharmaceuticals ACAD:US USD -53584000 7.52M
Adma Biologics ADMA:US USD 39.59M 45.65M
ALKERMES ALKS:US USD -47494000 26.91M
AstraZeneca AZN:LN USD 2.55B 1.46B
BioCryst Pharmaceuticals BCRX:US USD -28415000 17.9M
Bristol-Myers Squibb BMY:US USD 3.1B 1.15B
Dynavax Technologies DVAX:US USD -30248000 93.38M
Eli Lilly LLY:US USD 1.49B 342.4M
Esperion Therapeutics ESPR:US USD -48605000 6.09M
GlaxoSmithKline GSK:LN GBP 2.08B 215M
Halozyme Therapeutics HALO:US USD 53.8M 20.71M
Ionis Pharmaceuticals IONS:US USD -114148000 93.87M
J&J JNJ:US USD -737000000 4.94B
Marinus Pharmaceuticals MRNS:US USD -32963000 2.95M
Merck & Co MRK:US USD 3.72B 286M
Minerva Neurosciences NERV:US USD -5349000 279K
Neurocrine Biosciences NBIX:US USD -114200000 217.6M
Novartis NOVN:VX USD 2.86B 907M
Novavax NVAX:US USD -312768000 68.89M
Pfizer PFE:US USD 6.79B 1.62B
Roche Holding ROG:VX 5.93B 5.62B
Takeda 4502:JP JPY 88.56B 58.43B
Vanda Pharmaceuticals VNDA:US USD 2M 4.62M